|
Volumn 385, Issue 9976, 2015, Pages 1373-1375
|
Ebola: The battle plan must include specific treatments
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
FX 06;
UNCLASSIFIED DRUG;
ANTIVIRAL THERAPY;
ARTIFICIAL VENTILATION;
BIOSAFETY;
EBOLA HEMORRHAGIC FEVER;
EBOLAVIRUS;
EXPERIMENTAL THERAPY;
FLUID BALANCE;
HEALTH CARE PERSONNEL;
HEART DISEASE;
HUMAN;
INTENSIVE CARE;
MEDICAL CARE;
MULTIPLE ORGAN FAILURE;
NOTE;
PRIORITY JOURNAL;
RENAL REPLACEMENT THERAPY;
SURVIVAL RATE;
VASCULAR LEAK SYNDROME;
BLOOD VESSEL;
HEMORRHAGIC FEVER, EBOLA;
MALE;
PATHOPHYSIOLOGY;
BLOOD VESSELS;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
MALE;
MULTIPLE ORGAN FAILURE;
|
EID: 84928698500
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(14)62353-9 Document Type: Note |
Times cited : (5)
|
References (9)
|